Clinical Scorecard: Thyroid Activity and Overall Mortality in Relation to Multimorbidity: Findings from Two Population-Based Studies
At a Glance
Category
Detail
Condition
Thyroid dysfunction and multimorbidity
Key Mechanisms
Altered thyroid hormone levels (free T3 and free T4) influence mortality risk; nonthyroidal illness syndrome (NTIS) characterized by decreased free T3 without elevated TSH in chronic illness
Target Population
Adults from general population cohorts, stratified by disease status (no disease, 1 disease, multimorbidity)
Care Setting
Population-based cohort studies with clinical follow-up
Key Highlights
Higher free T4 concentrations are associated with increased all-cause mortality risk, especially in individuals with multimorbidity.
Lower free T3 concentrations are linked to poorer survival among individuals with 1 disease and multimorbidity.
Thyroid dysfunction effects on mortality are more pronounced in multimorbid individuals compared to those with no or single disease.
Guideline-Based Recommendations
Diagnosis
Measure thyroid function including free T3 and free T4 in adults, especially those with multimorbidity.
Exclude individuals on thyroid medications or with known thyroid disease when assessing thyroid function impact on mortality.
Management
Consider thyroid hormone status in the clinical evaluation of patients with multimorbidity.
Further research needed to determine implications for levothyroxine treatment in multimorbid populations.
Monitoring & Follow-up
Monitor thyroid hormone levels longitudinally in patients with multimorbidity to assess risk stratification.
Evaluate changes in free T3 and free T4 as potential prognostic markers for mortality.
Risks
Elevated free T4 may increase mortality risk in multimorbid patients.
Low free T3 levels may indicate poor prognosis in chronic illness and multimorbidity.
Patient & Prescribing Data
Adults without thyroid medication or diagnosed thyroid disease, stratified by disease burden
Current findings do not include levothyroxine users; future studies needed to assess treatment impact on mortality in multimorbidity.
Clinical Best Practices
Assess thyroid function comprehensively (free T3, free T4, TSH) in patients with multiple chronic diseases.
Recognize that thyroid hormone alterations may reflect disease burden and influence survival.
Integrate thyroid function testing into risk assessment models for patients with multimorbidity.
Avoid confounding by excluding patients on thyroid medications when evaluating thyroid function and mortality associations.
